PolyPid Ltd. (PYPD) stock
PYPDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$6.54+0.39 (+6.34%)
Close on Nov 17, 2026Market cap $119.05MP/E 3.1Yield –
PolyPid r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $23.81M, up 4.4% from the year before. The highest annual figure on record is $30.55M in fiscal 2021.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.81M | +4.4% |
| FY2024 | Dec 31, 2024 | $22.81M | +41.3% |
| FY2023 | Dec 31, 2023 | $16.15M | -42.3% |
| FY2022 | Dec 31, 2022 | $27.99M | -8.4% |
| FY2021 | Dec 31, 2021 | $30.55M | +80.2% |
| FY2020 | Dec 31, 2020 | $16.95M | +20.4% |
| FY2019 | Dec 31, 2019 | $14.08M | +12.2% |
| FY2018 | Dec 31, 2018 | $12.55M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | $6.22M | -16.5% |
| Q2 FY2024 | Jun 30, 2024 | $4.76M | +9.7% |
| Q2 FY2023 | Jun 30, 2023 | $3.96M | – |
| Q2 FY2022 | Jun 30, 2022 | $8.40M | – |
| Q2 FY2021 | Jun 30, 2021 | $7.44M | – |
| Q2 FY2020 | Jun 30, 2020 | $4.34M | – |
See a number that looks wrong?